top
Search terms
Results 1 - 4 of 4 - ordered by :
Eurointervention

EuroIntervention An analysis of the cost effectiveness of left atrial appendage closure for the prevention of stroke in patients with atrial fibrillation and absolute contraindications to warfarin ...

Date : 21/05/2013 Item size : 34047 bytes
Epeuropace

Recently, a novel oral anticoagulant, apixaban, and percutaneous left atrial appendage closure (LAAC) have emerged as safe and effective therapies for stroke risk reduction in these ...

Europace, CLINICAL RESEARCH, Vivek Y. Reddy, Ronald L. Akehurst, Shannon O. Armstrong, Stacey L. Amorosi, Nic Brereton, Deanna S. Hertz, David R. Holmes

Date : 01/07/2016 Item size : 261380 bytes
Epeuropace

Recent studies have reported the clinical benefits of percutaneous left atrial appendage closure (LAAC) for stroke prevention in atrial fibrillation (AF) relative to standard warfarin ...

EP Europace, Atrial fibrillation, Stacey L. Amorosi, Shannon Armstrong, Lisa Da Deppo, Susan Garfield, Kenneth Stein

Date : 01/08/2014 Item size : 215167 bytes
Ehjournal

Of note, patients with atrial fibrillation and heart failure have a higher risk of thrombo-embolic events and overall mortality compared with those with atrial fibrillation without heart failure as ...

European Heart Journal, ISSUE @ A GLANCE, Thomas F. Lüscher

Date : 14/08/2016 Item size : 184329 bytes